{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:29:07Z","timestamp":1760711347538,"version":"3.37.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012261","name":"Korea Ministry of the Interior and Safety","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jpba.2024.116148","type":"journal-article","created":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T01:50:13Z","timestamp":1713059413000},"page":"116148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A fatal case of desvenlafaxine and paroxetine poisoning"],"prefix":"10.1016","volume":"245","author":[{"given":"Sujin","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoseob","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanggil","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunwook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Seong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jpba.2024.116148_bib1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/14656566.2021.1900826","article-title":"Desvenlafaxine in the treatment of major depression: an updated overview","volume":"22","author":"Norman","year":"2021","journal-title":"Expert Opin. Pharmacother."},{"year":"2017","series-title":"Disposition of Toxic Drugs and Chemicals in Man\u201411th edition","author":"Baselt","key":"10.1016\/j.jpba.2024.116148_bib2"},{"issue":"3","key":"10.1016\/j.jpba.2024.116148_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/dmdi-2013-0053","article-title":"Venlafaxine pharmacokinetics focused on drug metabolism and potential biomarkers","volume":"29","author":"Magalh\u00e3es","year":"2014","journal-title":"Drug Metabol. Drug Interact."},{"issue":"6","key":"10.1016\/j.jpba.2024.116148_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/01.pra.0000341891.43501.6b","article-title":"Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system","volume":"14","author":"Preskorn","year":"2008","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.jpba.2024.116148_bib5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00228-010-0829-y","article-title":"Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes\u2013focus on venlafaxine and O-desmethylvenlafaxine","volume":"66","author":"Kandasamy","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116148_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/NDT.S157708","article-title":"Drug\u2013drug interactions involving antidepressants: focus on desvenlafaxine","author":"Low","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jpba.2024.116148_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00228-007-0453-7","article-title":"Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6* 3,* 4 or* 5 allele","volume":"64","author":"Hermann","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.jpba.2024.116148_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0091270008326716","article-title":"The effects of desvenlafaxine and paroxetine on the pharmacokinetics of the cytochrome P450 2D6 substrate desipramine in healthy adults","volume":"49","author":"Nichols","year":"2009","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.jpba.2024.116148_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/15563650.2016.1223847","article-title":"Desvenlafaxine overdose and the occurrence of serotonin toxicity, seizures and cardiovascular effects","volume":"55","author":"Cooper","year":"2017","journal-title":"Clin. Toxicol."},{"issue":"15","key":"10.1016\/j.jpba.2024.116148_bib10","first-page":"42","article-title":"SSRI safety in overdose","volume":"59","author":"Barbey","year":"1998","journal-title":"J. Clin. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpba.2024.116148_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/qjmed\/hcg062","article-title":"Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants","volume":"96","author":"Whyte","year":"2003","journal-title":"QJM"},{"issue":"4","key":"10.1016\/j.jpba.2024.116148_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/JCP.0b013e3181e6d686","article-title":"Retrospective analysis of suicidality in patients treated with the antidepressant desvenlafaxine","volume":"30","author":"Tourian","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpba.2024.116148_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00414-010-0461-5","article-title":"Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions","volume":"125","author":"Launiainen","year":"2011","journal-title":"Int. J. Leg. Med."},{"issue":"1","key":"10.1016\/j.jpba.2024.116148_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jchromb.2005.09.034","article-title":"Liquid chromatography\u2013tandem mass spectrometry (LC\u2013MS\u2013MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma","volume":"829","author":"Bhatt","year":"2005","journal-title":"J. Chromatogr. B"},{"issue":"4","key":"10.1016\/j.jpba.2024.116148_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jat\/20.4.266","article-title":"Two fatal cases of venlafaxine poisoning","volume":"20","author":"Parsons","year":"1996","journal-title":"J. Anal. Toxicol."},{"issue":"2","key":"10.1016\/j.jpba.2024.116148_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/15563650.2012.763133","article-title":"The spectrum of acute heart failure after venlafaxine overdose","volume":"51","author":"Batista","year":"2013","journal-title":"Clin. Toxicol."},{"issue":"12","key":"10.1016\/j.jpba.2024.116148_bib17","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1592\/phco.23.15.1668.31951","article-title":"Fatality related to a 30-g venlafaxine overdose","volume":"23","author":"Mazur","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.jpba.2024.116148_bib18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/j.1552-4604.1992.tb03875.x","article-title":"Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite","volume":"32","author":"Klamerus","year":"1992","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.jpba.2024.116148_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/IJPSYM.IJPSYM_397_17","article-title":"Desvenlafaxine overdose-induced toxic cardiomyopathy and acute left ventricular failure: a case report","volume":"40","author":"Goyal","year":"2018","journal-title":"Indian J. Psychol. Med."},{"issue":"1","key":"10.1016\/j.jpba.2024.116148_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/875512251102700107","article-title":"Comparison of desvenlafaxine and venlafaxine ingestions reported to Texas Poison Centers","volume":"27","author":"Forrester","year":"2011","journal-title":"J. Pharm. Technol."},{"issue":"2-3","key":"10.1016\/j.jpba.2024.116148_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.forsciint.2006.05.021","article-title":"Validation of new methods","volume":"165","author":"Peters","year":"2007","journal-title":"Forensic Sci. Int."},{"issue":"Suppl 1","key":"10.1016\/j.jpba.2024.116148_bib22","first-page":"S23","article-title":"Evaluating assay precision","volume":"29","author":"Chesher","year":"2008","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.jpba.2024.116148_bib23","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00216-012-6035-2","article-title":"Aspects of matrix effects in applications of liquid chromatography\u2013mass spectrometry to forensic and clinical toxicology\u2014a review","volume":"403","author":"Peters","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116148_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.110717","article-title":"A case of fatal intoxication by ingestion of an herbicide formulation containing fluroxypyr-meptyl and triclopyr","volume":"320","author":"Jang","year":"2021","journal-title":"Forensic Sci. Int."},{"issue":"10","key":"10.1016\/j.jpba.2024.116148_bib25","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1177\/1060028013501994","article-title":"A comparison of the risk of QT prolongation among SSRIs","volume":"47","author":"Funk","year":"2013","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.jpba.2024.116148_bib26","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1053\/j.jvca.2017.08.031","article-title":"Takotsubo cardiomyopathy and intraoperative cardiac arrest: is desvenlafaxine a contributing factor?","volume":"32","author":"Gurunathan","year":"2018","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.jpba.2024.116148_bib27","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.14497","article-title":"Concurrent serotonin syndrome and prolong QT interval induced by paroxetine overdose with isotretinoin","author":"Al-Radideh","year":"2021","journal-title":"Cureus 13(4"},{"issue":"4","key":"10.1016\/j.jpba.2024.116148_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.hlc.2011.12.004","article-title":"Occurrence of Tako-Tsubo cardiomyopathy in association with ingestion of serotonin\/noradrenaline reuptake inhibitors","volume":"21","author":"Neil","year":"2012","journal-title":"Heart, Lung Circ."},{"year":"2003","series-title":"Handbook of drug interactions: a clinical and forensic guide","author":"Mozayani","key":"10.1016\/j.jpba.2024.116148_bib29"},{"issue":"9","key":"10.1016\/j.jpba.2024.116148_bib30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/138920010794328887","article-title":"Metabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs: an analytical point of view","volume":"11","author":"Mandrioli","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jpba.2024.116148_bib31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2165\/00003088-199018040-00006","article-title":"Pilot study to determine the interaction of oxiracetam with antiepileptic drugs","volume":"18","author":"van Wieringen","year":"1990","journal-title":"Clin. Pharmacokinet."},{"issue":"2-3","key":"10.1016\/j.jpba.2024.116148_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0920-1211(91)90013-6","article-title":"No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin","volume":"10","author":"Andersen","year":"1991","journal-title":"Epilepsy Res"},{"year":"2009","series-title":"Handbook of Forensic Toxicology for Medical Examiners","author":"Molina","key":"10.1016\/j.jpba.2024.116148_bib33"},{"issue":"01\/02","key":"10.1016\/j.jpba.2024.116148_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpba.2024.116148_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-02915-5","article-title":"Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics","volume":"24","author":"Schulz","year":"2020","journal-title":"Crit. Care"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T23:46:23Z","timestamp":1720655183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524001882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":35,"alternative-id":["S0731708524001882"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116148","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A fatal case of desvenlafaxine and paroxetine poisoning","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116148"}}